These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relation between DNA ploidy and the clinical behavior of phyllodes tumors. Layfield LJ; Hart J; Neuwirth H; Bohman R; Trumbull WE; Giuliano AE Cancer; 1989 Oct; 64(7):1486-9. PubMed ID: 2550124 [TBL] [Abstract][Full Text] [Related]
3. DNA content and proliferative activity of cystosarcoma phyllodes of the breast. Potential prognostic significance. el-Naggar AK; Ro JY; McLemore D; Garnsy L Am J Clin Pathol; 1990 Apr; 93(4):480-5. PubMed ID: 2157332 [TBL] [Abstract][Full Text] [Related]
4. Ultrastructure of cystosarcoma phyllodes and fibroadenoma. A comparative study. Yeh IT; Francis DJ; Orenstein JM; Silverberg SG Am J Clin Pathol; 1985 Aug; 84(2):131-6. PubMed ID: 2992265 [TBL] [Abstract][Full Text] [Related]
5. Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H Cancer Res; 1993 Sep; 53(17):4071-4. PubMed ID: 8395336 [TBL] [Abstract][Full Text] [Related]
6. [Sarcomas originating in breast fibroadenomas (cystosarcoma phyllodes, malignant form). Considerations on 28 cases]. da Silva Neto JB; Giannotti Filho O AMB Rev Assoc Med Bras; 1979 Mar; 25(3):108-10. PubMed ID: 228358 [No Abstract] [Full Text] [Related]
7. Flow cytometric S fraction as a predictor of clinical outcome in cystosarcoma phyllodes. Palko MJ; Wang SE; Shackney SE; Cottington EM; Levitt SB; Hartsock RJ Arch Pathol Lab Med; 1990 Sep; 114(9):949-52. PubMed ID: 2167652 [TBL] [Abstract][Full Text] [Related]
8. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations. Grimes MM Mod Pathol; 1992 May; 5(3):232-9. PubMed ID: 1323101 [TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group. Collin F; Chassevent A; Bonichon F; Bertrand G; Terrier P; Coindra JM Cancer; 1997 Jun; 79(12):2371-9. PubMed ID: 9191525 [TBL] [Abstract][Full Text] [Related]
10. Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast. Barbosa ML; Ribeiro EM; Silva GF; Maciel ME; Lima RS; Cavalli LR; Cavalli IJ Cancer Genet Cytogenet; 2004 Oct; 154(2):156-9. PubMed ID: 15474152 [TBL] [Abstract][Full Text] [Related]
11. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. Niezabitowski A; Lackowska B; Rys J; Kruczak A; Kowalska T; Mitus J; Reinfuss M; Markiewicz D Breast Cancer Res Treat; 2001 Jan; 65(1):77-85. PubMed ID: 11245343 [TBL] [Abstract][Full Text] [Related]
12. Phyllodes tumors of the breast: correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome. Samaratunga H; Clarke B; Owen L; Bryson G; Swanson C Pathol Int; 2001 Nov; 51(11):866-73. PubMed ID: 11844053 [TBL] [Abstract][Full Text] [Related]
13. Fibroadenoma and cystosarcoma phyllodes of the male breast. Ansah-Boateng Y; Tavassoli FA Mod Pathol; 1992 Mar; 5(2):114-6. PubMed ID: 1315437 [TBL] [Abstract][Full Text] [Related]
14. Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma. Bot FJ; Sleddens HF; Dinjens WN Diagn Mol Pathol; 1998 Dec; 7(6):295-301. PubMed ID: 10207667 [TBL] [Abstract][Full Text] [Related]
15. Practical aspects in the diagnosis and management of cystosarcoma phyllodes. Hart J; Layfield LJ; Trumbull WE; Brayton D; Barker WF; Giuliano AE Arch Surg; 1988 Sep; 123(9):1079-83. PubMed ID: 2843145 [TBL] [Abstract][Full Text] [Related]
16. [Flow cytometric analysis of DNA from 98 cases of soft tissue tumors and its clinical significance]. Li S Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):281-4, 318. PubMed ID: 2086097 [TBL] [Abstract][Full Text] [Related]
17. Flow cytometric nuclear DNA content of fresh and paraffin-embedded tissues of breast carcinomas and fibroadenomas. De Vita R; Calugi A; Eleuteri P; Maggi O; Nassuato C; Vecchione A Eur J Basic Appl Histochem; 1991; 35(3):233-44. PubMed ID: 1718443 [TBL] [Abstract][Full Text] [Related]
18. Sarcomas of the Breast with a Spotlight on Angiosarcoma and Cystosarcoma Phyllodes. Thornton K Surg Oncol Clin N Am; 2016 Oct; 25(4):713-20. PubMed ID: 27591494 [TBL] [Abstract][Full Text] [Related]
19. Phyllodes tumor: clinicopathologic review of 60 patients and flow cytometric analysis in 30 patients. Keelan PA; Myers JL; Wold LE; Katzmann JA; Gibney DJ Hum Pathol; 1992 Sep; 23(9):1048-54. PubMed ID: 1325408 [TBL] [Abstract][Full Text] [Related]
20. Tubular carcinoma developing within a recurring cystosarcoma phyllodes of the breast. Leong AS; Meredith DJ Cancer; 1980 Oct; 46(8):1863-7. PubMed ID: 6253046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]